Literature DB >> 33231881

Socioeconomic status and the effectiveness of treatment for first-episode psychosis.

Daniel Bennett1, Robert Rosenheck2.   

Abstract

OBJECTIVE: To assess whether patient socioeconomic status (SES) moderates the effectiveness of coordinated specialty care for first-episode psychosis and to investigate possible mechanisms. DATA SOURCES: A secondary analysis of data from the RAISE-ETP Trial, which was conducted from 2010-2014. STUDY
DESIGN: RAISE-ETP was a cluster-randomized trial comparing a coordinated specialty care (CSC) intervention called NAVIGATE with usual community care. We constructed a patient SES index based on parental education, parental occupational prestige, and race/ethnicity. After identifying correlates of SES, we used OLS regression analysis to estimate treatment effects on the major study outcomes across quartiles of the index. We also examined whether correlates of SES including the duration of untreated psychosis (DUP), and participation in NAVIGATE might account for the observed difference in effectiveness of CSC by SES. PRINCIPAL
FINDINGS: The trial sample had a similar SES distribution to the US population, and SES was positively correlated with all mental health outcomes and several potential moderators at baseline. CSC substantially improved the main trial outcomes compared to community care for patients in the highest SES quartile but had small and statistically insignificant benefits for the remaining 75% of patients. Intervention participation rates and several potential moderators did not explain this disparity.
CONCLUSIONS: CSC may be more effective for high-SES patients with early psychosis than low-SES patients. Additional research is needed to understand why CSC is less effective for low-SES patients and to develop methods to increase effectiveness for this subgroup. © Health Research and Educational Trust.

Entities:  

Keywords:  health status disparities; psychotic disorders; schizophrenia; social class; socioeconomic factors

Mesh:

Year:  2020        PMID: 33231881      PMCID: PMC8143679          DOI: 10.1111/1475-6773.13606

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.734


  29 in total

1.  Measuring socioeconomic status: reliability and preliminary validity for different approaches.

Authors:  Paul T Cirino; Christopher E Chin; Rose A Sevcik; Maryanne Wolf; Maureen Lovett; Robin D Morris
Journal:  Assessment       Date:  2002-06

2.  Poverty and response to treatment among panic disorder patients in primary care.

Authors:  Peter Roy-Byrne; Cathy Sherbourne; Jeanne Miranda; Murray Stein; Michelle Craske; Daniela Golinelli; Greer Sullivan
Journal:  Am J Psychiatry       Date:  2006-08       Impact factor: 18.112

3.  The influence of perceived social support on medication adherence in first-episode psychosis.

Authors:  Mark Rabinovitch; Clifford Cassidy; Norbert Schmitz; Ridha Joober; Ashok Malla
Journal:  Can J Psychiatry       Date:  2013-01       Impact factor: 4.356

4.  Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study.

Authors:  Kim T Mueser; Piper S Meyer-Kalos; Shirley M Glynn; David W Lynde; Delbert G Robinson; Susan Gingerich; David L Penn; Corrine Cather; Jennifer D Gottlieb; Patricia Marcy; Jennifer L Wiseman; Sheena Potretzke; Mary F Brunette; Nina R Schooler; Jean Addington; Robert A Rosenheck; Sue E Estroff; John M Kane
Journal:  Schizophr Res       Date:  2018-08-20       Impact factor: 4.939

5.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

6.  Predictors of outcome in outpatients with anxiety disorders: the Leiden routine outcome monitoring study.

Authors:  A Schat; M S van Noorden; M J Noom; E J Giltay; N J A van der Wee; R R J M Vermeiren; F G Zitman
Journal:  J Psychiatr Res       Date:  2013-09-18       Impact factor: 4.791

7.  Relationship between household income and mental disorders: findings from a population-based longitudinal study.

Authors:  Jitender Sareen; Tracie O Afifi; Katherine A McMillan; Gordon J G Asmundson
Journal:  Arch Gen Psychiatry       Date:  2011-04

8.  The Stigma Scale: development of a standardised measure of the stigma of mental illness.

Authors:  Michael King; Sokratis Dinos; Jenifer Shaw; Robert Watson; Scott Stevens; Filippo Passetti; Scott Weich; Marc Serfaty
Journal:  Br J Psychiatry       Date:  2007-03       Impact factor: 9.319

9.  Differences in treatment effect among clinical subgroups in a randomized clinical trial of long-acting injectable risperidone and oral antipsychotics in unstable chronic schizophrenia.

Authors:  Sarah M Leatherman; Matthew H Liang; John H Krystal; Robert A Lew; Danielle Valley; Soe Soe Thwin; Robert A Rosenheck
Journal:  J Nerv Ment Dis       Date:  2014-01       Impact factor: 2.254

10.  Socioeconomic status and the effectiveness of treatment for first-episode psychosis.

Authors:  Daniel Bennett; Robert Rosenheck
Journal:  Health Serv Res       Date:  2020-11-24       Impact factor: 3.734

View more
  4 in total

1.  Clinical and psychosocial outcomes of Black Americans in the Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE-ETP) study.

Authors:  Kim T Mueser; David L Penn; Arundati Nagendra; David M Weiss; Carrington Merritt; Corinne Cather; Effua E Sosoo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-08-06       Impact factor: 4.519

2.  Internet Use among Patients with Schizophrenia and Depression.

Authors:  Nikola Žaja; Jakša Vukojević; Tvrtko Žarko; Marko Marelić; Domagoj Vidović; Tea Vukušić Rukavina
Journal:  Int J Environ Res Public Health       Date:  2022-05-07       Impact factor: 4.614

3.  Need for Ethnic and Population Diversity in Psychosis Research.

Authors:  Carla Burkhard; Saba Cicek; Ran Barzilay; Rajiv Radhakrishnan; Sinan Guloksuz
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

4.  Socioeconomic status and the effectiveness of treatment for first-episode psychosis.

Authors:  Daniel Bennett; Robert Rosenheck
Journal:  Health Serv Res       Date:  2020-11-24       Impact factor: 3.734

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.